Skip to Content

A891 40 mg (Methylphenidate Hydrochloride Extended-Release 40 mg)

Pill with imprint A891 40 mg is Yellow & White, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release 40 mg. It is supplied by Actavis Pharma, Inc..

Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 40 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for A891 40 mg

Methylphenidate hydrochloride extended-release 40 mg A891 40 mg

Methylphenidate Hydrochloride Extended-Release

A891 40 mg
40 mg
Yellow & White
Prescription only
Drug Class
Cns stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.